Clinical Trials Directory

Trials / Conditions / Acute Intermittent Porphyria

Acute Intermittent Porphyria

10 registered clinical trials studyying Acute Intermittent Porphyria.

StatusTrialSponsorPhase
CompletedENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Po
NCT03338816
Alnylam PharmaceuticalsPhase 3
CompletedAssessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
NCT02943213
Cycle Pharmaceuticals Ltd.Phase 1
CompletedA Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Interm
NCT02949830
Alnylam PharmaceuticalsPhase 1 / Phase 2
TerminatedPanhematin for Prevention of Acute Attacks of Porphyria
NCT02922413
The University of Texas Medical Branch, GalvestonPhase 2
CompletedA Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)
NCT02452372
Alnylam PharmaceuticalsPhase 1
Active Not RecruitingAcute Porphyria Biomarkers for Disease Activity
NCT02935400
The University of Texas Medical Branch, Galveston—
CompletedPhase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porp
NCT02082860
Digna Biotech S.L.Phase 1
Active Not RecruitingDental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)
NCT01617642
Nordlandssykehuset HF—
CompletedObservational Study of Acute Intermittent Porphyria Patients
NCT02076763
Digna Biotech S.L.—
CompletedPorphozym in the Treatment of Acute Attacks in AIP
NCT00418795
Zymenex A/SPhase 2 / Phase 3